Global Copovidone VA 64 Market Growth 2026-2032
The global Copovidone VA 64 market size is predicted to grow from US$ 73.87 million in 2025 to US$ 99 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Copovidone VA 64 (also known as PVP/VA64) is a water-soluble polymer resin copolymerized from N-vinylpyrrolidone (NVP) and vinyl acetate (VA), commonly used as a pharmaceutical excipient and cosmetic ingredient. It possesses excellent adhesion, film-forming properties, plasticity, and low hygroscopicity, making it a multifunctional material.
<p class="tw-data-text tw-text-large tw-ta" data-placeholder="??" id="tw-target-text" role="text" tabindex="-1" data-ved="2ahUKEwia5uGJ1JORAxVjJEQIHRvRNbEQ3ewLegQIHhAV" dir="ltr" aria-label="???The core raw materials include N-vinylpyrrolidone (NVP) and vinyl acetate (VA). NVP is a complex fine chemical, typically synthesized from butanediol and acetylene/ammonia. VA is produced by reacting ethylene with acetic acid.
Global sales in 2024 were approximately 2,710 tons, with an average market price of approximately US$26/kg. The size of a single production line varies depending on the production process and investment scale. Industry gross profit margins range from 20% to 35%.">The core raw materials include N-vinylpyrrolidone (NVP) and vinyl acetate (VA). NVP is a complex fine chemical, typically synthesized from butanediol and acetylene/ammonia. VA is produced by reacting ethylene with acetic acid.Global sales in 2024 were approximately 2,710 tons, with an average market price of approximately US$26/kg. The size of a single production line varies depending on the production process and investment scale. Industry gross profit margins range from 20% to 35%.
United States market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Copovidone VA 64 players cover BASF, JRS Pharma, JH Nanhang Life Sciences, Huangshan Bonsun Pharmaceutical, Boai NKY, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Copovidone VA 64 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Copovidone VA 64 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Copovidone VA 64 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Copovidone VA 64 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Copovidone VA 64.
This report presents a comprehensive overview, market shares, and growth opportunities of Copovidone VA 64 market by product type, application, key manufacturers and key regions and countries.
Copovidone VA 64 (also known as PVP/VA64) is a water-soluble polymer resin copolymerized from N-vinylpyrrolidone (NVP) and vinyl acetate (VA), commonly used as a pharmaceutical excipient and cosmetic ingredient. It possesses excellent adhesion, film-forming properties, plasticity, and low hygroscopicity, making it a multifunctional material.
<p class="tw-data-text tw-text-large tw-ta" data-placeholder="??" id="tw-target-text" role="text" tabindex="-1" data-ved="2ahUKEwia5uGJ1JORAxVjJEQIHRvRNbEQ3ewLegQIHhAV" dir="ltr" aria-label="???The core raw materials include N-vinylpyrrolidone (NVP) and vinyl acetate (VA). NVP is a complex fine chemical, typically synthesized from butanediol and acetylene/ammonia. VA is produced by reacting ethylene with acetic acid.
Global sales in 2024 were approximately 2,710 tons, with an average market price of approximately US$26/kg. The size of a single production line varies depending on the production process and investment scale. Industry gross profit margins range from 20% to 35%.">The core raw materials include N-vinylpyrrolidone (NVP) and vinyl acetate (VA). NVP is a complex fine chemical, typically synthesized from butanediol and acetylene/ammonia. VA is produced by reacting ethylene with acetic acid.Global sales in 2024 were approximately 2,710 tons, with an average market price of approximately US$26/kg. The size of a single production line varies depending on the production process and investment scale. Industry gross profit margins range from 20% to 35%.
United States market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Copovidone VA 64 is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Copovidone VA 64 players cover BASF, JRS Pharma, JH Nanhang Life Sciences, Huangshan Bonsun Pharmaceutical, Boai NKY, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Copovidone VA 64 Industry Forecast” looks at past sales and reviews total world Copovidone VA 64 sales in 2025, providing a comprehensive analysis by region and market sector of projected Copovidone VA 64 sales for 2026 through 2032. With Copovidone VA 64 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Copovidone VA 64 industry.This Insight Report provides a comprehensive analysis of the global Copovidone VA 64 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Copovidone VA 64 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Copovidone VA 64 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Copovidone VA 64 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Copovidone VA 64.
This report presents a comprehensive overview, market shares, and growth opportunities of Copovidone VA 64 market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Powder
- Particles
Segmentation by Grade:
- Medical Grade
- Food Grade
- Industrial Grade
Segmentation by Application:
- Adhesives
- Film-forming Agents
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF
- JRS Pharma
- JH Nanhang Life Sciences
- Huangshan Bonsun Pharmaceutical
- Boai NKY
- Jiaozuo Zhongwei Special Products Pharmaceutical
- Henan Pengfei New Materials
- Shanxi Jinyang Pharmaceutical Excipients
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Copovidone VA 64 market?
- What factors are driving Copovidone VA 64 market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Copovidone VA 64 market opportunities vary by end market size?
- How does Copovidone VA 64 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Copovidone VA 64 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Copovidone VA 64 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Copovidone VA 64 by Country/Region, 2021, 2025 & 2032
2.2 Copovidone VA 64 Segment by Type
2.2.1 Powder
2.2.2 Particles
2.2.3 Copovidone VA 64 Sales by Type
2.2.3.1 Global Copovidone VA 64 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Copovidone VA 64 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Copovidone VA 64 Sale Price by Type (2021-2026)
2.3 Copovidone VA 64 Segment by Grade
2.3.1 Medical Grade
2.3.2 Food Grade
2.3.3 Industrial Grade
2.3.4 Copovidone VA 64 Sales by Grade
2.3.4.1 Global Copovidone VA 64 Sales Market Share by Grade (2021-2026)
2.3.4.2 Global Copovidone VA 64 Revenue and Market Share by Grade (2021-2026)
2.3.4.3 Global Copovidone VA 64 Sale Price by Grade (2021-2026)
2.4 Copovidone VA 64 Segment by Application
2.4.1 Adhesives
2.4.2 Film-forming Agents
2.4.3 Other
2.4.4 Copovidone VA 64 Sales by Application
2.4.4.1 Global Copovidone VA 64 Sale Market Share by Application (2021-2026)
2.4.4.2 Global Copovidone VA 64 Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Copovidone VA 64 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Copovidone VA 64 Breakdown Data by Company
3.1.1 Global Copovidone VA 64 Annual Sales by Company (2021-2026)
3.1.2 Global Copovidone VA 64 Sales Market Share by Company (2021-2026)
3.2 Global Copovidone VA 64 Annual Revenue by Company (2021-2026)
3.2.1 Global Copovidone VA 64 Revenue by Company (2021-2026)
3.2.2 Global Copovidone VA 64 Revenue Market Share by Company (2021-2026)
3.3 Global Copovidone VA 64 Sale Price by Company
3.4 Key Manufacturers Copovidone VA 64 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Copovidone VA 64 Product Location Distribution
3.4.2 Players Copovidone VA 64 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COPOVIDONE VA 64 BY GEOGRAPHIC REGION
4.1 World Historic Copovidone VA 64 Market Size by Geographic Region (2021-2026)
4.1.1 Global Copovidone VA 64 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Copovidone VA 64 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Copovidone VA 64 Market Size by Country/Region (2021-2026)
4.2.1 Global Copovidone VA 64 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Copovidone VA 64 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Copovidone VA 64 Sales Growth
4.4 APAC Copovidone VA 64 Sales Growth
4.5 Europe Copovidone VA 64 Sales Growth
4.6 Middle East & Africa Copovidone VA 64 Sales Growth
5 AMERICAS
5.1 Americas Copovidone VA 64 Sales by Country
5.1.1 Americas Copovidone VA 64 Sales by Country (2021-2026)
5.1.2 Americas Copovidone VA 64 Revenue by Country (2021-2026)
5.2 Americas Copovidone VA 64 Sales by Type (2021-2026)
5.3 Americas Copovidone VA 64 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Copovidone VA 64 Sales by Region
6.1.1 APAC Copovidone VA 64 Sales by Region (2021-2026)
6.1.2 APAC Copovidone VA 64 Revenue by Region (2021-2026)
6.2 APAC Copovidone VA 64 Sales by Type (2021-2026)
6.3 APAC Copovidone VA 64 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Copovidone VA 64 by Country
7.1.1 Europe Copovidone VA 64 Sales by Country (2021-2026)
7.1.2 Europe Copovidone VA 64 Revenue by Country (2021-2026)
7.2 Europe Copovidone VA 64 Sales by Type (2021-2026)
7.3 Europe Copovidone VA 64 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Copovidone VA 64 by Country
8.1.1 Middle East & Africa Copovidone VA 64 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Copovidone VA 64 Revenue by Country (2021-2026)
8.2 Middle East & Africa Copovidone VA 64 Sales by Type (2021-2026)
8.3 Middle East & Africa Copovidone VA 64 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Copovidone VA 64
10.3 Manufacturing Process Analysis of Copovidone VA 64
10.4 Industry Chain Structure of Copovidone VA 64
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Copovidone VA 64 Distributors
11.3 Copovidone VA 64 Customer
12 WORLD FORECAST REVIEW FOR COPOVIDONE VA 64 BY GEOGRAPHIC REGION
12.1 Global Copovidone VA 64 Market Size Forecast by Region
12.1.1 Global Copovidone VA 64 Forecast by Region (2027-2032)
12.1.2 Global Copovidone VA 64 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Copovidone VA 64 Forecast by Type (2027-2032)
12.7 Global Copovidone VA 64 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Copovidone VA 64 Product Portfolios and Specifications
13.1.3 BASF Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Copovidone VA 64 Product Portfolios and Specifications
13.2.3 JRS Pharma Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 JH Nanhang Life Sciences
13.3.1 JH Nanhang Life Sciences Company Information
13.3.2 JH Nanhang Life Sciences Copovidone VA 64 Product Portfolios and Specifications
13.3.3 JH Nanhang Life Sciences Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 JH Nanhang Life Sciences Main Business Overview
13.3.5 JH Nanhang Life Sciences Latest Developments
13.4 Huangshan Bonsun Pharmaceutical
13.4.1 Huangshan Bonsun Pharmaceutical Company Information
13.4.2 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
13.4.3 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Huangshan Bonsun Pharmaceutical Main Business Overview
13.4.5 Huangshan Bonsun Pharmaceutical Latest Developments
13.5 Boai NKY
13.5.1 Boai NKY Company Information
13.5.2 Boai NKY Copovidone VA 64 Product Portfolios and Specifications
13.5.3 Boai NKY Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Boai NKY Main Business Overview
13.5.5 Boai NKY Latest Developments
13.6 Jiaozuo Zhongwei Special Products Pharmaceutical
13.6.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information
13.6.2 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
13.6.3 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiaozuo Zhongwei Special Products Pharmaceutical Main Business Overview
13.6.5 Jiaozuo Zhongwei Special Products Pharmaceutical Latest Developments
13.7 Henan Pengfei New Materials
13.7.1 Henan Pengfei New Materials Company Information
13.7.2 Henan Pengfei New Materials Copovidone VA 64 Product Portfolios and Specifications
13.7.3 Henan Pengfei New Materials Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Henan Pengfei New Materials Main Business Overview
13.7.5 Henan Pengfei New Materials Latest Developments
13.8 Shanxi Jinyang Pharmaceutical Excipients
13.8.1 Shanxi Jinyang Pharmaceutical Excipients Company Information
13.8.2 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Portfolios and Specifications
13.8.3 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanxi Jinyang Pharmaceutical Excipients Main Business Overview
13.8.5 Shanxi Jinyang Pharmaceutical Excipients Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Copovidone VA 64 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Copovidone VA 64 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Copovidone VA 64 by Country/Region, 2021, 2025 & 2032
2.2 Copovidone VA 64 Segment by Type
2.2.1 Powder
2.2.2 Particles
2.2.3 Copovidone VA 64 Sales by Type
2.2.3.1 Global Copovidone VA 64 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Copovidone VA 64 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Copovidone VA 64 Sale Price by Type (2021-2026)
2.3 Copovidone VA 64 Segment by Grade
2.3.1 Medical Grade
2.3.2 Food Grade
2.3.3 Industrial Grade
2.3.4 Copovidone VA 64 Sales by Grade
2.3.4.1 Global Copovidone VA 64 Sales Market Share by Grade (2021-2026)
2.3.4.2 Global Copovidone VA 64 Revenue and Market Share by Grade (2021-2026)
2.3.4.3 Global Copovidone VA 64 Sale Price by Grade (2021-2026)
2.4 Copovidone VA 64 Segment by Application
2.4.1 Adhesives
2.4.2 Film-forming Agents
2.4.3 Other
2.4.4 Copovidone VA 64 Sales by Application
2.4.4.1 Global Copovidone VA 64 Sale Market Share by Application (2021-2026)
2.4.4.2 Global Copovidone VA 64 Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Copovidone VA 64 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Copovidone VA 64 Breakdown Data by Company
3.1.1 Global Copovidone VA 64 Annual Sales by Company (2021-2026)
3.1.2 Global Copovidone VA 64 Sales Market Share by Company (2021-2026)
3.2 Global Copovidone VA 64 Annual Revenue by Company (2021-2026)
3.2.1 Global Copovidone VA 64 Revenue by Company (2021-2026)
3.2.2 Global Copovidone VA 64 Revenue Market Share by Company (2021-2026)
3.3 Global Copovidone VA 64 Sale Price by Company
3.4 Key Manufacturers Copovidone VA 64 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Copovidone VA 64 Product Location Distribution
3.4.2 Players Copovidone VA 64 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COPOVIDONE VA 64 BY GEOGRAPHIC REGION
4.1 World Historic Copovidone VA 64 Market Size by Geographic Region (2021-2026)
4.1.1 Global Copovidone VA 64 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Copovidone VA 64 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Copovidone VA 64 Market Size by Country/Region (2021-2026)
4.2.1 Global Copovidone VA 64 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Copovidone VA 64 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Copovidone VA 64 Sales Growth
4.4 APAC Copovidone VA 64 Sales Growth
4.5 Europe Copovidone VA 64 Sales Growth
4.6 Middle East & Africa Copovidone VA 64 Sales Growth
5 AMERICAS
5.1 Americas Copovidone VA 64 Sales by Country
5.1.1 Americas Copovidone VA 64 Sales by Country (2021-2026)
5.1.2 Americas Copovidone VA 64 Revenue by Country (2021-2026)
5.2 Americas Copovidone VA 64 Sales by Type (2021-2026)
5.3 Americas Copovidone VA 64 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Copovidone VA 64 Sales by Region
6.1.1 APAC Copovidone VA 64 Sales by Region (2021-2026)
6.1.2 APAC Copovidone VA 64 Revenue by Region (2021-2026)
6.2 APAC Copovidone VA 64 Sales by Type (2021-2026)
6.3 APAC Copovidone VA 64 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Copovidone VA 64 by Country
7.1.1 Europe Copovidone VA 64 Sales by Country (2021-2026)
7.1.2 Europe Copovidone VA 64 Revenue by Country (2021-2026)
7.2 Europe Copovidone VA 64 Sales by Type (2021-2026)
7.3 Europe Copovidone VA 64 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Copovidone VA 64 by Country
8.1.1 Middle East & Africa Copovidone VA 64 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Copovidone VA 64 Revenue by Country (2021-2026)
8.2 Middle East & Africa Copovidone VA 64 Sales by Type (2021-2026)
8.3 Middle East & Africa Copovidone VA 64 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Copovidone VA 64
10.3 Manufacturing Process Analysis of Copovidone VA 64
10.4 Industry Chain Structure of Copovidone VA 64
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Copovidone VA 64 Distributors
11.3 Copovidone VA 64 Customer
12 WORLD FORECAST REVIEW FOR COPOVIDONE VA 64 BY GEOGRAPHIC REGION
12.1 Global Copovidone VA 64 Market Size Forecast by Region
12.1.1 Global Copovidone VA 64 Forecast by Region (2027-2032)
12.1.2 Global Copovidone VA 64 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Copovidone VA 64 Forecast by Type (2027-2032)
12.7 Global Copovidone VA 64 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Copovidone VA 64 Product Portfolios and Specifications
13.1.3 BASF Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Copovidone VA 64 Product Portfolios and Specifications
13.2.3 JRS Pharma Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 JH Nanhang Life Sciences
13.3.1 JH Nanhang Life Sciences Company Information
13.3.2 JH Nanhang Life Sciences Copovidone VA 64 Product Portfolios and Specifications
13.3.3 JH Nanhang Life Sciences Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 JH Nanhang Life Sciences Main Business Overview
13.3.5 JH Nanhang Life Sciences Latest Developments
13.4 Huangshan Bonsun Pharmaceutical
13.4.1 Huangshan Bonsun Pharmaceutical Company Information
13.4.2 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
13.4.3 Huangshan Bonsun Pharmaceutical Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Huangshan Bonsun Pharmaceutical Main Business Overview
13.4.5 Huangshan Bonsun Pharmaceutical Latest Developments
13.5 Boai NKY
13.5.1 Boai NKY Company Information
13.5.2 Boai NKY Copovidone VA 64 Product Portfolios and Specifications
13.5.3 Boai NKY Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Boai NKY Main Business Overview
13.5.5 Boai NKY Latest Developments
13.6 Jiaozuo Zhongwei Special Products Pharmaceutical
13.6.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information
13.6.2 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
13.6.3 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiaozuo Zhongwei Special Products Pharmaceutical Main Business Overview
13.6.5 Jiaozuo Zhongwei Special Products Pharmaceutical Latest Developments
13.7 Henan Pengfei New Materials
13.7.1 Henan Pengfei New Materials Company Information
13.7.2 Henan Pengfei New Materials Copovidone VA 64 Product Portfolios and Specifications
13.7.3 Henan Pengfei New Materials Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Henan Pengfei New Materials Main Business Overview
13.7.5 Henan Pengfei New Materials Latest Developments
13.8 Shanxi Jinyang Pharmaceutical Excipients
13.8.1 Shanxi Jinyang Pharmaceutical Excipients Company Information
13.8.2 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Portfolios and Specifications
13.8.3 Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanxi Jinyang Pharmaceutical Excipients Main Business Overview
13.8.5 Shanxi Jinyang Pharmaceutical Excipients Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Copovidone VA 64 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Copovidone VA 64 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Particles
Table 5. Global Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 6. Global Copovidone VA 64 Sales Market Share by Type (2021-2026)
Table 7. Global Copovidone VA 64 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Copovidone VA 64 Revenue Market Share by Type (2021-2026)
Table 9. Global Copovidone VA 64 Sale Price by Type (2021-2026) & (US$/kg)
Table 10. Major Players of Medical Grade
Table 11. Major Players of Food Grade
Table 12. Major Players of Industrial Grade
Table 13. Global Copovidone VA 64 Sales by Grade (2021-2026) & (Tons)
Table 14. Global Copovidone VA 64 Sales Market Share by Grade (2021-2026)
Table 15. Global Copovidone VA 64 Revenue by Grade (2021-2026) & ($ million)
Table 16. Global Copovidone VA 64 Revenue Market Share by Grade (2021-2026)
Table 17. Global Copovidone VA 64 Sale Price by Grade (2021-2026) & (US$/kg)
Table 18. Global Copovidone VA 64 Sale by Application (2021-2026) & (Tons)
Table 19. Global Copovidone VA 64 Sale Market Share by Application (2021-2026)
Table 20. Global Copovidone VA 64 Revenue by Application (2021-2026) & ($ million)
Table 21. Global Copovidone VA 64 Revenue Market Share by Application (2021-2026)
Table 22. Global Copovidone VA 64 Sale Price by Application (2021-2026) & (US$/kg)
Table 23. Global Copovidone VA 64 Sales by Company (2021-2026) & (Tons)
Table 24. Global Copovidone VA 64 Sales Market Share by Company (2021-2026)
Table 25. Global Copovidone VA 64 Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Copovidone VA 64 Revenue Market Share by Company (2021-2026)
Table 27. Global Copovidone VA 64 Sale Price by Company (2021-2026) & (US$/kg)
Table 28. Key Manufacturers Copovidone VA 64 Producing Area Distribution and Sales Area
Table 29. Players Copovidone VA 64 Products Offered
Table 30. Copovidone VA 64 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Copovidone VA 64 Sales by Geographic Region (2021-2026) & (Tons)
Table 34. Global Copovidone VA 64 Sales Market Share Geographic Region (2021-2026)
Table 35. Global Copovidone VA 64 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Copovidone VA 64 Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Copovidone VA 64 Sales by Country/Region (2021-2026) & (Tons)
Table 38. Global Copovidone VA 64 Sales Market Share by Country/Region (2021-2026)
Table 39. Global Copovidone VA 64 Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Copovidone VA 64 Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 42. Americas Copovidone VA 64 Sales Market Share by Country (2021-2026)
Table 43. Americas Copovidone VA 64 Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 45. Americas Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 46. APAC Copovidone VA 64 Sales by Region (2021-2026) & (Tons)
Table 47. APAC Copovidone VA 64 Sales Market Share by Region (2021-2026)
Table 48. APAC Copovidone VA 64 Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 50. APAC Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 51. Europe Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 52. Europe Copovidone VA 64 Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 54. Europe Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 55. Middle East & Africa Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 56. Middle East & Africa Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 58. Middle East & Africa Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 59. Key Market Drivers & Growth Opportunities of Copovidone VA 64
Table 60. Key Market Challenges & Risks of Copovidone VA 64
Table 61. Key Industry Trends of Copovidone VA 64
Table 62. Copovidone VA 64 Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Copovidone VA 64 Distributors List
Table 65. Copovidone VA 64 Customer List
Table 66. Global Copovidone VA 64 Sales Forecast by Region (2027-2032) & (Tons)
Table 67. Global Copovidone VA 64 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Americas Copovidone VA 64 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Copovidone VA 64 Sales Forecast by Region (2027-2032) & (Tons)
Table 71. APAC Copovidone VA 64 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 73. Europe Copovidone VA 64 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 75. Middle East & Africa Copovidone VA 64 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Copovidone VA 64 Sales Forecast by Type (2027-2032) & (Tons)
Table 77. Global Copovidone VA 64 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Copovidone VA 64 Sales Forecast by Application (2027-2032) & (Tons)
Table 79. Global Copovidone VA 64 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. BASF Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 81. BASF Copovidone VA 64 Product Portfolios and Specifications
Table 82. BASF Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 83. BASF Main Business
Table 84. BASF Latest Developments
Table 85. JRS Pharma Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 86. JRS Pharma Copovidone VA 64 Product Portfolios and Specifications
Table 87. JRS Pharma Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 88. JRS Pharma Main Business
Table 89. JRS Pharma Latest Developments
Table 90. JH Nanhang Life Sciences Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 91. JH Nanhang Life Sciences Copovidone VA 64 Product Portfolios and Specifications
Table 92. JH Nanhang Life Sciences Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 93. JH Nanhang Life Sciences Main Business
Table 94. JH Nanhang Life Sciences Latest Developments
Table 95. Huangshan Bonsun Pharmaceutical Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 96. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
Table 97. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 98. Huangshan Bonsun Pharmaceutical Main Business
Table 99. Huangshan Bonsun Pharmaceutical Latest Developments
Table 100. Boai NKY Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 101. Boai NKY Copovidone VA 64 Product Portfolios and Specifications
Table 102. Boai NKY Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 103. Boai NKY Main Business
Table 104. Boai NKY Latest Developments
Table 105. Jiaozuo Zhongwei Special Products Pharmaceutical Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 106. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
Table 107. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 108. Jiaozuo Zhongwei Special Products Pharmaceutical Main Business
Table 109. Jiaozuo Zhongwei Special Products Pharmaceutical Latest Developments
Table 110. Henan Pengfei New Materials Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 111. Henan Pengfei New Materials Copovidone VA 64 Product Portfolios and Specifications
Table 112. Henan Pengfei New Materials Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 113. Henan Pengfei New Materials Main Business
Table 114. Henan Pengfei New Materials Latest Developments
Table 115. Shanxi Jinyang Pharmaceutical Excipients Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 116. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Portfolios and Specifications
Table 117. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 118. Shanxi Jinyang Pharmaceutical Excipients Main Business
Table 119. Shanxi Jinyang Pharmaceutical Excipients Latest Developments
Table 1. Copovidone VA 64 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Copovidone VA 64 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Particles
Table 5. Global Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 6. Global Copovidone VA 64 Sales Market Share by Type (2021-2026)
Table 7. Global Copovidone VA 64 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Copovidone VA 64 Revenue Market Share by Type (2021-2026)
Table 9. Global Copovidone VA 64 Sale Price by Type (2021-2026) & (US$/kg)
Table 10. Major Players of Medical Grade
Table 11. Major Players of Food Grade
Table 12. Major Players of Industrial Grade
Table 13. Global Copovidone VA 64 Sales by Grade (2021-2026) & (Tons)
Table 14. Global Copovidone VA 64 Sales Market Share by Grade (2021-2026)
Table 15. Global Copovidone VA 64 Revenue by Grade (2021-2026) & ($ million)
Table 16. Global Copovidone VA 64 Revenue Market Share by Grade (2021-2026)
Table 17. Global Copovidone VA 64 Sale Price by Grade (2021-2026) & (US$/kg)
Table 18. Global Copovidone VA 64 Sale by Application (2021-2026) & (Tons)
Table 19. Global Copovidone VA 64 Sale Market Share by Application (2021-2026)
Table 20. Global Copovidone VA 64 Revenue by Application (2021-2026) & ($ million)
Table 21. Global Copovidone VA 64 Revenue Market Share by Application (2021-2026)
Table 22. Global Copovidone VA 64 Sale Price by Application (2021-2026) & (US$/kg)
Table 23. Global Copovidone VA 64 Sales by Company (2021-2026) & (Tons)
Table 24. Global Copovidone VA 64 Sales Market Share by Company (2021-2026)
Table 25. Global Copovidone VA 64 Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Copovidone VA 64 Revenue Market Share by Company (2021-2026)
Table 27. Global Copovidone VA 64 Sale Price by Company (2021-2026) & (US$/kg)
Table 28. Key Manufacturers Copovidone VA 64 Producing Area Distribution and Sales Area
Table 29. Players Copovidone VA 64 Products Offered
Table 30. Copovidone VA 64 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Copovidone VA 64 Sales by Geographic Region (2021-2026) & (Tons)
Table 34. Global Copovidone VA 64 Sales Market Share Geographic Region (2021-2026)
Table 35. Global Copovidone VA 64 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Copovidone VA 64 Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Copovidone VA 64 Sales by Country/Region (2021-2026) & (Tons)
Table 38. Global Copovidone VA 64 Sales Market Share by Country/Region (2021-2026)
Table 39. Global Copovidone VA 64 Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Copovidone VA 64 Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 42. Americas Copovidone VA 64 Sales Market Share by Country (2021-2026)
Table 43. Americas Copovidone VA 64 Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 45. Americas Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 46. APAC Copovidone VA 64 Sales by Region (2021-2026) & (Tons)
Table 47. APAC Copovidone VA 64 Sales Market Share by Region (2021-2026)
Table 48. APAC Copovidone VA 64 Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 50. APAC Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 51. Europe Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 52. Europe Copovidone VA 64 Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 54. Europe Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 55. Middle East & Africa Copovidone VA 64 Sales by Country (2021-2026) & (Tons)
Table 56. Middle East & Africa Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Copovidone VA 64 Sales by Type (2021-2026) & (Tons)
Table 58. Middle East & Africa Copovidone VA 64 Sales by Application (2021-2026) & (Tons)
Table 59. Key Market Drivers & Growth Opportunities of Copovidone VA 64
Table 60. Key Market Challenges & Risks of Copovidone VA 64
Table 61. Key Industry Trends of Copovidone VA 64
Table 62. Copovidone VA 64 Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Copovidone VA 64 Distributors List
Table 65. Copovidone VA 64 Customer List
Table 66. Global Copovidone VA 64 Sales Forecast by Region (2027-2032) & (Tons)
Table 67. Global Copovidone VA 64 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Americas Copovidone VA 64 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Copovidone VA 64 Sales Forecast by Region (2027-2032) & (Tons)
Table 71. APAC Copovidone VA 64 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 73. Europe Copovidone VA 64 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Copovidone VA 64 Sales Forecast by Country (2027-2032) & (Tons)
Table 75. Middle East & Africa Copovidone VA 64 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Copovidone VA 64 Sales Forecast by Type (2027-2032) & (Tons)
Table 77. Global Copovidone VA 64 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Copovidone VA 64 Sales Forecast by Application (2027-2032) & (Tons)
Table 79. Global Copovidone VA 64 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. BASF Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 81. BASF Copovidone VA 64 Product Portfolios and Specifications
Table 82. BASF Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 83. BASF Main Business
Table 84. BASF Latest Developments
Table 85. JRS Pharma Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 86. JRS Pharma Copovidone VA 64 Product Portfolios and Specifications
Table 87. JRS Pharma Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 88. JRS Pharma Main Business
Table 89. JRS Pharma Latest Developments
Table 90. JH Nanhang Life Sciences Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 91. JH Nanhang Life Sciences Copovidone VA 64 Product Portfolios and Specifications
Table 92. JH Nanhang Life Sciences Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 93. JH Nanhang Life Sciences Main Business
Table 94. JH Nanhang Life Sciences Latest Developments
Table 95. Huangshan Bonsun Pharmaceutical Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 96. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
Table 97. Huangshan Bonsun Pharmaceutical Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 98. Huangshan Bonsun Pharmaceutical Main Business
Table 99. Huangshan Bonsun Pharmaceutical Latest Developments
Table 100. Boai NKY Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 101. Boai NKY Copovidone VA 64 Product Portfolios and Specifications
Table 102. Boai NKY Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 103. Boai NKY Main Business
Table 104. Boai NKY Latest Developments
Table 105. Jiaozuo Zhongwei Special Products Pharmaceutical Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 106. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Product Portfolios and Specifications
Table 107. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 108. Jiaozuo Zhongwei Special Products Pharmaceutical Main Business
Table 109. Jiaozuo Zhongwei Special Products Pharmaceutical Latest Developments
Table 110. Henan Pengfei New Materials Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 111. Henan Pengfei New Materials Copovidone VA 64 Product Portfolios and Specifications
Table 112. Henan Pengfei New Materials Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 113. Henan Pengfei New Materials Main Business
Table 114. Henan Pengfei New Materials Latest Developments
Table 115. Shanxi Jinyang Pharmaceutical Excipients Basic Information, Copovidone VA 64 Manufacturing Base, Sales Area and Its Competitors
Table 116. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Product Portfolios and Specifications
Table 117. Shanxi Jinyang Pharmaceutical Excipients Copovidone VA 64 Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 118. Shanxi Jinyang Pharmaceutical Excipients Main Business
Table 119. Shanxi Jinyang Pharmaceutical Excipients Latest Developments
LIST OF FIGURES
Figure 1. Picture of Copovidone VA 64
Figure 2. Copovidone VA 64 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Copovidone VA 64 Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Copovidone VA 64 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Copovidone VA 64 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Copovidone VA 64 Sales Market Share by Country/Region (2025)
Figure 10. Copovidone VA 64 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Particles
Figure 13. Global Copovidone VA 64 Sales Market Share by Type in 2026
Figure 14. Global Copovidone VA 64 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Medical Grade
Figure 16. Product Picture of Food Grade
Figure 17. Product Picture of Industrial Grade
Figure 18. Global Copovidone VA 64 Sales Market Share by Grade in 2026
Figure 19. Global Copovidone VA 64 Revenue Market Share by Grade (2021-2026)
Figure 20. Copovidone VA 64 Consumed in Adhesives
Figure 21. Global Copovidone VA 64 Market: Adhesives (2021-2026) & (Tons)
Figure 22. Copovidone VA 64 Consumed in Film-forming Agents
Figure 23. Global Copovidone VA 64 Market: Film-forming Agents (2021-2026) & (Tons)
Figure 24. Copovidone VA 64 Consumed in Other
Figure 25. Global Copovidone VA 64 Market: Other (2021-2026) & (Tons)
Figure 26. Global Copovidone VA 64 Sale Market Share by Application (2025)
Figure 27. Global Copovidone VA 64 Revenue Market Share by Application in 2026
Figure 28. Copovidone VA 64 Sales by Company in 2026 (Tons)
Figure 29. Global Copovidone VA 64 Sales Market Share by Company in 2026
Figure 30. Copovidone VA 64 Revenue by Company in 2026 ($ millions)
Figure 31. Global Copovidone VA 64 Revenue Market Share by Company in 2026
Figure 32. Global Copovidone VA 64 Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Copovidone VA 64 Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 35. Americas Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 36. APAC Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 37. APAC Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 38. Europe Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 39. Europe Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 41. Middle East & Africa Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 42. Americas Copovidone VA 64 Sales Market Share by Country in 2026
Figure 43. Americas Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Figure 44. Americas Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 45. Americas Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 46. United States Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Copovidone VA 64 Sales Market Share by Region in 2026
Figure 51. APAC Copovidone VA 64 Revenue Market Share by Region (2021-2026)
Figure 52. APAC Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 53. APAC Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 54. China Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 58. India Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Copovidone VA 64 Sales Market Share by Country in 2026
Figure 62. Europe Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Figure 63. Europe Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 64. Europe Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 65. Germany Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 66. France Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Copovidone VA 64 Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 73. Egypt Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Copovidone VA 64 in 2026
Figure 79. Manufacturing Process Analysis of Copovidone VA 64
Figure 80. Industry Chain Structure of Copovidone VA 64
Figure 81. Channels of Distribution
Figure 82. Global Copovidone VA 64 Sales Market Forecast by Region (2027-2032)
Figure 83. Global Copovidone VA 64 Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Copovidone VA 64 Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Copovidone VA 64 Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Copovidone VA 64 Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Copovidone VA 64 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Copovidone VA 64
Figure 2. Copovidone VA 64 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Copovidone VA 64 Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Copovidone VA 64 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Copovidone VA 64 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Copovidone VA 64 Sales Market Share by Country/Region (2025)
Figure 10. Copovidone VA 64 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Particles
Figure 13. Global Copovidone VA 64 Sales Market Share by Type in 2026
Figure 14. Global Copovidone VA 64 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Medical Grade
Figure 16. Product Picture of Food Grade
Figure 17. Product Picture of Industrial Grade
Figure 18. Global Copovidone VA 64 Sales Market Share by Grade in 2026
Figure 19. Global Copovidone VA 64 Revenue Market Share by Grade (2021-2026)
Figure 20. Copovidone VA 64 Consumed in Adhesives
Figure 21. Global Copovidone VA 64 Market: Adhesives (2021-2026) & (Tons)
Figure 22. Copovidone VA 64 Consumed in Film-forming Agents
Figure 23. Global Copovidone VA 64 Market: Film-forming Agents (2021-2026) & (Tons)
Figure 24. Copovidone VA 64 Consumed in Other
Figure 25. Global Copovidone VA 64 Market: Other (2021-2026) & (Tons)
Figure 26. Global Copovidone VA 64 Sale Market Share by Application (2025)
Figure 27. Global Copovidone VA 64 Revenue Market Share by Application in 2026
Figure 28. Copovidone VA 64 Sales by Company in 2026 (Tons)
Figure 29. Global Copovidone VA 64 Sales Market Share by Company in 2026
Figure 30. Copovidone VA 64 Revenue by Company in 2026 ($ millions)
Figure 31. Global Copovidone VA 64 Revenue Market Share by Company in 2026
Figure 32. Global Copovidone VA 64 Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Copovidone VA 64 Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 35. Americas Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 36. APAC Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 37. APAC Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 38. Europe Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 39. Europe Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Copovidone VA 64 Sales 2021-2026 (Tons)
Figure 41. Middle East & Africa Copovidone VA 64 Revenue 2021-2026 ($ millions)
Figure 42. Americas Copovidone VA 64 Sales Market Share by Country in 2026
Figure 43. Americas Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Figure 44. Americas Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 45. Americas Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 46. United States Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Copovidone VA 64 Sales Market Share by Region in 2026
Figure 51. APAC Copovidone VA 64 Revenue Market Share by Region (2021-2026)
Figure 52. APAC Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 53. APAC Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 54. China Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 58. India Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Copovidone VA 64 Sales Market Share by Country in 2026
Figure 62. Europe Copovidone VA 64 Revenue Market Share by Country (2021-2026)
Figure 63. Europe Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 64. Europe Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 65. Germany Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 66. France Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Copovidone VA 64 Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Copovidone VA 64 Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Copovidone VA 64 Sales Market Share by Application (2021-2026)
Figure 73. Egypt Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Copovidone VA 64 Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Copovidone VA 64 in 2026
Figure 79. Manufacturing Process Analysis of Copovidone VA 64
Figure 80. Industry Chain Structure of Copovidone VA 64
Figure 81. Channels of Distribution
Figure 82. Global Copovidone VA 64 Sales Market Forecast by Region (2027-2032)
Figure 83. Global Copovidone VA 64 Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Copovidone VA 64 Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Copovidone VA 64 Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Copovidone VA 64 Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Copovidone VA 64 Revenue Market Share Forecast by Application (2027-2032)
